Research Article
Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer
Table 2
Univariate and multivariate Cox regression analysis of OS in CC patients.
| Variables | Univariate | Multivariate | HR | 95% CI | | HR | 95% CI | |
| Age (>45 vs. ≤45 years) | 1.331 | 0.712–2.372 | 0.643 | — | Pathological type (squamous cell carcinoma vs. adenocarcinoma) | 1.106 | 0.903–1.341 | 0.874 | — | FIGO stage (≥IB2 vs. IA1-IB1) | 2.818 | 1.746–4.112 | <0.001 | 2.015 | 1.464–3.046 | 0.017 | Differentiation (poorly differentiated vs. well and moderately differentiated) | 1.874 | 1.412–3.648 | 0.012 | 1.593 | 1.198–2.749 | 0.156 | Lymph node involvement (positive vs. negative) | 4.621 | 2.815–7.492 | <0.001 | 2.907 | 1.315–7.124 | <0.001 | Tumor size (>2 vs. ≤2 cm) | 1.536 | 1.115–2.896 | 0.257 | — | Lymphovascular space invasion (positive vs. negative) | 2.172 | 1.721–3.824 | 0.024 | 1.514 | 1.139–2.472 | 0.297 | Serum ACTN4 levels (high vs. low levels) | 2.442 | 1.806–4.113 | <0.001 | 1.785 | 1.406–3.127 | 0.082 |
|
|